Levosalbutamol Completed Phase 3 Trials for Asthma / Bronchoconstriction Treatment

Indications	Status	Purpose	Phase
DBCOND0013565 (Asthma) DBCOND0020847 (Bronchoconstriction)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00685425	Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol	Levosalbutamol (DB13139) Salbutamol (DB01001)